0,651  0,010  Vasodilator, peripheral
0,576  0,004  Cyclic AMP phosphodiesterase inhibitor
0,513  0,005  Phosphodiesterase inhibitor
0,516  0,020  CYP2C19 inhibitor
0,482  0,004  Phosphodiesterase IV inhibitor
0,502  0,024  CYP2C9 inhibitor
0,486  0,015  Tumour necrosis factor alpha release inhibitor
0,486  0,030  Antiallergic
0,508  0,057  Caspase 9 stimulant
0,434  0,004  Phosphodiesterase 3A inhibitor
0,446  0,020  CYP3A4 inhibitor
0,478  0,062  MAP kinase 1 inhibitor
0,417  0,005  CYP2B6 inhibitor
0,429  0,025  CYP1A2 inhibitor
0,420  0,018  Calcium channel activator
0,418  0,020  Vasodilator
0,467  0,070  Antineoplastic (solid tumors)
0,402  0,020  Antineoplastic enhancer
0,389  0,010  Pneumotoxic
0,403  0,025  Cardiodepressant
0,429  0,056  Antipruritic, allergic
0,374  0,004  Phosphodiesterase 4D inhibitor
0,429  0,061  5 Hydroxytryptamine release inhibitor
0,427  0,062  Histamine release inhibitor
0,384  0,040  CTGF expression inhibitor
0,382  0,040  CYP2D6 inhibitor
0,383  0,041  Vasodilator, coronary
0,340  0,004  Phosphodiesterase 4A inhibitor
0,353  0,025  Platelet aggregation inhibitor
0,329  0,004  Phosphodiesterase III inhibitor
0,322  0,004  Phosphodiesterase 4C inhibitor
0,346  0,029  Peroxidase inhibitor
0,319  0,005  Electron transport complex I inhibitor
0,348  0,036  Myocardial infarction treatment
0,312  0,005  Phosphodiesterase 4B inhibitor
0,370  0,071  Transcription factor NF kappa B inhibitor
0,370  0,073  Antiasthmatic
0,332  0,037  UGT1A6 substrate
0,338  0,043  Cardiotonic
0,297  0,004  Phosphodiesterase 3B inhibitor
0,341  0,057  Antineoplastic (melanoma)
0,359  0,078  Ulceration
0,358  0,078  Toll-Like receptor 7 agonist
0,340  0,062  Caspase 3 stimulant
0,317  0,040  Antimitotic
0,333  0,058  Spasmolytic
0,354  0,080  Toll-Like receptor agonist
0,323  0,053  Antineoplastic (small cell lung cancer)
0,313  0,046  Superoxide dismutase inhibitor
0,322  0,061  Aldehyde oxidase inhibitor
0,331  0,070  FMO1 substrate
0,279  0,022  Tubulin antagonist
0,354  0,097  TNF expression inhibitor
0,319  0,067  Antineoplastic (brain cancer)
0,308  0,058  UGT2B4 substrate
0,254  0,006  Phosphodiesterase I inhibitor
0,304  0,059  UGT1A9 substrate
0,248  0,004  Acetylcholine release stimulant
0,305  0,063  Hypoxia-inducible factor 1 alpha inhibitor
0,315  0,082  Cholesterol antagonist
0,305  0,077  12-Lipoxygenase inhibitor
0,294  0,074  Lipoxygenase inhibitor
0,284  0,064  DNA damaging
0,246  0,028  UGT2B15 substrate
0,247  0,034  Nitric-oxide synthase stimulant
0,278  0,066  GST M1-1 substrate
0,245  0,032  Tumour necrosis factor antagonist
0,213  0,011  Antihelmintic (Trematoda)
0,224  0,023  UGT2B10 substrate
0,264  0,068  Hypoglycemic
0,259  0,068  Cardiovascular analeptic
0,212  0,022  Cystathionine beta-synthase inhibitor
0,214  0,023  Platelet activating factor antagonist
0,236  0,047  Neurotrophic factor enhancer
0,193  0,005  Smo receptor antagonist
0,324  0,137  Calcium channel L-type activator
0,226  0,039  Histone acetyltransferase inhibitor
0,210  0,024  Vascular endothelial growth factor 1 antagonist
0,189  0,005  Antifungal (Pneumocystis)
0,201  0,018  Bronchodilator
0,284  0,101  Angiogenesis inhibitor
0,262  0,083  Ca(v)3.3 blocker
0,250  0,071  Antiamyloidogenic
0,235  0,056  VCAM1 expression inhibitor
0,256  0,080  Radiosensitizer
0,253  0,078  Aryl hydrocarbon receptor agonist
0,236  0,062  Amyloid beta aggregation inhibitor
0,247  0,074  Heart failure treatment
0,222  0,049  UGT1A4 substrate
0,266  0,095  Nootropic
0,246  0,076  Antidiabetic symptomatic
0,224  0,055  Non-steroidal antiinflammatory agent
0,178  0,010  Antiprotozoal (Toxoplasma)
0,247  0,081  Antineoplastic (bladder cancer)
0,234  0,068  Antihypotensive
0,242  0,077  Antiprotozoal (Leishmania)
0,248  0,083  5 Hydroxytryptamine uptake stimulant
0,282  0,120  CYP2C9 substrate
0,239  0,078  NOS2 expression inhibitor
0,257  0,099  Metabolic disease treatment
0,162  0,006  Phosphodiesterase 1B inhibitor
0,166  0,011  Toll-Like receptor 3 antagonist
0,309  0,158  Alzheimer's disease treatment
0,189  0,040  Cytokine production inhibitor
0,244  0,097  Antineoplastic (pancreatic cancer)
0,152  0,005  Phosphodiesterase 1C inhibitor
0,277  0,130  Antineoplastic (breast cancer)
0,240  0,094  Huntington's disease treatment
0,146  0,004  Potassium channel small-conductance Ca-activated blocker
0,173  0,033  Nav1.6 sodium channel blocker
0,281  0,143  15-Lipoxygenase inhibitor
0,142  0,005  Potassium channel (Ca-activated) blocker
0,167  0,030  Beta amyloid protein antagonist
0,205  0,070  Age-related macular degeneration treatment
0,139  0,005  Poly(ADP-ribose) polymerase inhibitor
0,232  0,099  5 Hydroxytryptamine release stimulant
0,156  0,023  HIV-1 integrase (Overall Integration) inhibitor
0,238  0,108  Insulysin inhibitor
0,201  0,071  UGT1A1 substrate
0,203  0,074  Septic shock treatment
0,223  0,095  Antineoplastic (sarcoma)
0,130  0,005  Poly(ADP-ribose) polymerase 1 inhibitor
0,236  0,111  Antihypoxic
0,210  0,086  RNA-directed DNA polymerase inhibitor
0,195  0,071  5 Hydroxytryptamine 3E antagonist
0,316  0,192  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,143  0,021  Platelet growth factor antagonist
0,172  0,051  Genotoxic
0,154  0,035  GST P1-1 substrate
0,155  0,036  Interleukin 1b antagonist
0,189  0,070  Antieczematic atopic
0,224  0,107  Antineoplastic (ovarian cancer)
0,169  0,052  Skeletal muscle relaxant
0,245  0,128  Antineoplastic (lung cancer)
0,201  0,085  Antineoplastic (glioblastoma multiforme)
0,128  0,012  Granulocyte macrophage colony stimulating factor agonist
0,178  0,063  Antimutagenic
0,118  0,007  Phosphodiesterase 1A inhibitor
0,141  0,030  Dementia treatment
0,168  0,057  Heat shock protein 90 antagonist
0,244  0,134  Sodium/bile acid cotransporter inhibitor
0,286  0,176  Cyclophilin D inhibitor
0,286  0,176  Antidiabetic
0,174  0,065  Aldehyde oxidase substrate
0,171  0,062  Antianorexic
0,204  0,097  Antineoplastic (glioma)
0,164  0,057  Activin receptor-like kinase 2 inhibitor
0,171  0,064  Restenosis treatment
0,135  0,030  Vascular dementia treatment
0,206  0,101  Antihypercholesterolemic
0,226  0,121  CYP1A2 substrate
0,154  0,050  Toll-Like receptor 2 antagonist
0,137  0,035  Platelet activating factor alpha antagonist
0,175  0,074  Succinate dehydrogenase inhibitor
0,177  0,077  LDLR expression enhancer
0,187  0,087  Insulin sensitizer
0,174  0,075  MAP kinase kinase 5 inhibitor
0,158  0,059  Ca2+/calmodulin-dependent protein kinase kinase B inhibitor
0,147  0,050  Epidermal growth factor receptor kinase inhibitor
0,155  0,059  Antianemic
0,125  0,031  Insulin growth factor antagonist
0,155  0,061  Movement disorders treatment
0,118  0,025  Alpha 2d adrenoreceptor antagonist
0,279  0,188  Apoptosis agonist
0,154  0,063  Antiprotozoal (Coccidial)
0,145  0,057  Heat shock protein 70 antagonist
0,169  0,081  Antineoplastic (gastric cancer)
0,170  0,084  Diabetic retinopathy treatment
0,179  0,094  Pyruvate kinase inhibitor
0,176  0,092  Growth factor agonist
0,209  0,127  Antineoplastic (colorectal cancer)
0,144  0,062  Interleukin 1 antagonist
0,148  0,067  Vascular endothelial growth factor 3 antagonist
0,124  0,043  Proto-oncogene tyrosine-protein kinase Kit inhibitor
0,218  0,139  FMO3 substrate
0,164  0,085  Phobic disorders treatment
0,149  0,070  Growth factor antagonist
0,226  0,148  Antithrombotic
0,211  0,133  Prostate cancer treatment
0,203  0,126  Amyotrophic lateral sclerosis treatment
0,133  0,056  Antineoplastic (uterine cancer)
0,101  0,026  Phosphodiesterase 5A inhibitor
0,204  0,128  CYP2C19 substrate
0,101  0,027  Lipase inhibitor
0,176  0,102  VEGF expression inhibitor
0,148  0,076  GABA C receptor rho-2 antagonist
0,150  0,079  Cyclin-dependent kinase 8 inhibitor
0,099  0,028  Phosphodiesterase V inhibitor
0,196  0,126  Antineoplastic (colon cancer)
0,149  0,078  CF transmembrane conductance regulator agonist
0,107  0,038  Histamine H1 receptor antagonist
0,082  0,013  Phosphodiesterase X inhibitor
0,082  0,013  Phosphodiesterase 10A inhibitor
0,150  0,083  Carcinogenic, group 1
0,123  0,057  Microtubule formation inhibitor
0,079  0,013  Topoisomerase II beta inhibitor
0,203  0,139  Antiischemic
0,106  0,042  Carcinogenic, group 2A
0,116  0,053  HDL-cholesterol increasing
0,089  0,026  Beta tubulin antagonist
0,154  0,091  Antianginal
0,164  0,101  Antiarrhythmic
0,185  0,122  Antineoplastic (renal cancer)
0,109  0,046  UGT2B11 substrate
0,087  0,025  Orexin receptor 1 antagonist
0,142  0,081  MAP kinase 3 inhibitor
0,151  0,090  Muscle relaxant
0,181  0,120  Antineoplastic (non-small cell lung cancer)
0,097  0,036  Macrophage migration inhibitory factor inhibitor
0,114  0,053  DOPA decarboxylase inhibitor
0,176  0,116  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,140  0,081  Hemostatic
0,207  0,149  Ca2+/calmodulin-dependent kinase II alpha inhibitor
0,128  0,070  Allergic rhinitis treatment
0,082  0,025  Orexin receptor antagonist
0,176  0,119  Antineoplastic (cervical cancer)
0,099  0,043  Alpha 1 adrenoreceptor antagonist
0,145  0,089  Melanin inhibitor
0,064  0,008  Dihydrofolate reductase inhibitor
0,068  0,014  Alpha 1L adrenoreceptor antagonist
0,147  0,092  Arachidonic acid antagonist
0,081  0,027  Aromatase inhibitor
0,071  0,017  Ryanodine receptor antagonist
0,076  0,023  Heat shock protein 90 beta antagonist
0,174  0,121  Antineoplastic (lymphocytic leukemia)
0,075  0,022  Transcription factor RelA inhibitor
0,106  0,053  Alpha adrenoreceptor antagonist
0,128  0,076  Sodium channel blocker
0,073  0,021  Phosphodiesterase II inhibitor
0,128  0,076  Sodium channel (voltage-gated) blocker
0,061  0,009  Diamine oxidase inhibitor
0,074  0,022  Alpha tubulin antagonist
0,079  0,029  Glutamate (mGluR7) antagonist
0,150  0,100  3C-like protease (Human coronavirus) inhibitor
0,111  0,061  Choleretic
0,093  0,044  Myeloperoxidase inhibitor
0,107  0,057  Gastric antisecretory
0,125  0,077  Vanilloid 1 agonist
0,077  0,029  Beta adrenoreceptor antagonist
0,091  0,043  NAD(P)H dehydrogenase (quinone) inhibitor
0,102  0,055  Interleukin 1 beta converting enzyme inhibitor
0,170  0,123  Fibrosis treatment
0,117  0,070  Retinopathy treatment
0,124  0,079  Toll-Like receptor antagonist
0,052  0,007  Melatonin receptor 1A agonist
0,115  0,071  Anesthetic local
0,065  0,021  Phosphodiesterase 2A inhibitor
0,104  0,062  MAO A inhibitor
0,148  0,106  Neurotensin receptor agonist
0,081  0,039  Purinergic P2X2 antagonist
0,101  0,059  Sphingomyelinase inhibitor
0,146  0,105  Cyclin-dependent kinase 3 inhibitor
0,213  0,172  GST A substrate
0,085  0,045  Nicotinic alpha4beta2 receptor antagonist
0,064  0,024  Proto-oncogene tyrosine-protein kinase Met inhibitor
0,049  0,009  Vanilloid 3 antagonist
0,058  0,018  Dopamine beta hydroxylase inhibitor
0,137  0,097  Interferon gamma antagonist
0,120  0,081  Antibacterial (Helicobacter pylori)
0,045  0,007  Thiazolidinedione
0,133  0,095  Adenylate cyclase stimulant
0,146  0,108  ATPase inhibitor
0,161  0,124  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,201  0,164  Antileukemic
0,046  0,009  Cholesterol ester transfer protein antagonist
0,078  0,041  S-adenosyl-L-methionine decarboxylase inhibitor
0,115  0,080  Nav1.3 sodium channel blocker
0,114  0,079  Antiseptic
0,193  0,158  Antineoplastic (multiple myeloma)
0,117  0,083  Antihyperlipoproteinemic
0,120  0,086  Alkaline phosphatase inhibitor
0,099  0,066  Hedgehog signaling inhibitor
0,067  0,034  Calcium channel P-type blocker
0,163  0,130  Free radical scavenger
0,092  0,060  Hepatocyte growth factor antagonist
0,122  0,090  Protein kinase stimulant
0,103  0,071  Protein kinase C gamma inhibitor
0,092  0,061  Antiadrenergic
0,072  0,041  Acetylcholine M5 receptor agonist
0,077  0,046  Phosphodiesterase VI inhibitor
0,154  0,124  Focal adhesion kinase 2 inhibitor
0,137  0,108  Muscular dystrophy treatment
0,108  0,079  Interleukin 8 antagonist
0,114  0,085  Acetylcholinesterase inhibitor
0,120  0,091  Antineoplastic (squamous cell carcinoma)
0,149  0,120  I kappa B kinase epsilon inhibitor
0,103  0,075  SULT1A1 substrate
0,194  0,166  AR expression inhibitor
0,029  0,001  Insulin like growth factor 3 antagonist
0,073  0,045  Bulimia treatment
0,032  0,004  Antibiotic Trimethoprim-like
0,076  0,049  Alpha 1b adrenoreceptor antagonist
0,116  0,088  NADPH oxidase inhibitor
0,104  0,078  Nav1.5 sodium channel blocker
0,064  0,038  Alpha 2 adrenoreceptor agonist
0,090  0,064  Alcohol dehydrogenase inhibitor
0,077  0,052  Keratolytic
0,179  0,155  5 Hydroxytryptamine 1E antagonist
0,043  0,018  Orexin receptor 2 antagonist
0,091  0,067  Posttraumatic stress disorder treatment
0,137  0,114  Sensitization
0,132  0,109  Aldose reductase substrate
0,078  0,055  Antidote, organophosphates
0,134  0,111  Antipruritic, non-allergic
0,086  0,063  Tocolytic
0,075  0,053  CYP2A6 inhibitor
0,043  0,021  5 Hydroxytryptamine 2B agonist
0,057  0,036  5 Hydroxytryptamine 7 agonist
0,088  0,067  Antihistaminic
0,088  0,068  Breast cancer-resistant protein inhibitor
0,145  0,125  P-glycoprotein inhibitor
0,038  0,018  Free fatty acid receptor 1 antagonist
0,089  0,069  Obsessive-compulsive disorder treatment
0,097  0,078  Monophenol monooxygenase inhibitor
0,077  0,058  Acetylcholine nicotinic antagonist
0,093  0,075  Glutamate (mGluR7) agonist
0,080  0,061  5 Hydroxytryptamine 2C antagonist
0,165  0,147  Antioxidant
0,180  0,162  Antiviral (West Nile virus)
0,102  0,084  TRPA1 agonist
0,121  0,104  Chemopreventive
0,066  0,049  Alpha adrenoreceptor agonist
0,158  0,141  Antiviral (HIV)
0,087  0,071  Protein kinase C zeta inhibitor
0,072  0,056  Cushing's syndrome treatment
0,035  0,020  Melatonin 2 agonist
0,080  0,065  Epidermal growth factor antagonist
0,078  0,063  Phosphodiesterase XI inhibitor
0,078  0,063  Phosphodiesterase 11A inhibitor
0,042  0,027  Liver X receptor alpha agonist
0,106  0,091  Amylase inhibitor
0,029  0,015  Hedgehog signaling activator
0,105  0,091  Shock treatment
0,021  0,009  Alpha 2b adrenoreceptor agonist
0,063  0,051  Uterine relaxant
0,056  0,044  Alpha 1d adrenoreceptor antagonist
0,109  0,097  DNA repair enzyme inhibitor
0,064  0,052  Nav1.7 sodium channel blocker
0,066  0,055  Histidine decarboxylase inhibitor
0,062  0,052  Neuronal nicotinic receptor antagonist
0,116  0,105  Cytidine deaminase inhibitor
0,038  0,027  Vesicle monoamine transporter inhibitor
0,077  0,067  Histamine antagonist
0,057  0,047  Potassium channel intermediate-conductance Ca-activated blocker
0,079  0,069  Adrenaline antagonist
0,112  0,102  Antiprotozoal (Trichomonas)
0,037  0,028  Glutamate (mGluR group II) antagonist
0,192  0,184  ICAM1 expression inhibitor
0,064  0,056  Endocannabinoid uptake inhibitor
0,107  0,099  Coagulant
0,175  0,167  Chemoprotective
0,101  0,093  Antiprotozoal (Babesia)
0,150  0,142  Antiglaucomic
0,116  0,108  Pancreatic disorders treatment
0,181  0,173  Tyrosine 3 hydroxylase inhibitor
0,104  0,097  Cyclooxygenase 3 inhibitor
0,034  0,028  Inosine monophosphate dehydrogenase inhibitor
0,143  0,136  Abortion inducer
0,120  0,114  UGT1A3 substrate
0,142  0,136  Death-associated protein kinase 3 inhibitor
0,124  0,118  Macular degeneration treatment
0,028  0,023  Glutamate (mGluR2) antagonist
0,097  0,091  Cholesterol synthesis inhibitor
0,084  0,078  DNA directed RNA polymerase inhibitor
0,019  0,014  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,064  0,059  HIV-1 integrase inhibitor
0,053  0,047  Immunoglobulin Fc receptor antagonist
0,013  0,007  Melatonin 2 antagonist
0,072  0,068  Carbonic anhydrase VI inhibitor
0,169  0,165  Proliferative diseases treatment
0,095  0,091  Antifungal (Aspergillus)
0,076  0,072  Caspase 7 inhibitor
0,126  0,122  Uterine stimulant
0,026  0,023  Liver X receptor beta antagonist
0,129  0,126  Interleukin 6 antagonist
0,080  0,077  Antidote, mercury
0,105  0,102  Antismoking
0,100  0,097  Myasthenia Gravis treatment
0,107  0,105  Gastritis treatment
0,081  0,079  5-Lipoxygenase inhibitor
0,021  0,019  CYP24 inhibitor
0,026  0,024  Nicotinic alpha4beta2 receptor agonist
0,020  0,019  Glutaminyl-peptide cyclotransferase inhibitor
0,017  0,016  Alpha 2c adrenoreceptor agonist
0,047  0,046  Glucose-6-phosphate translocase inhibitor

